North America Hypertrophic and Keloid Scar Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)

No. of Pages: 89    |    Report Code: TIPRE00025199    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Hypertrophic and Keloid Scar Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Hypertrophic and Keloid Scar Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Advantages of Laser Treatment
5.2 Market Opportunities
  • 5.2.1 Advances in Stem Cell and Tissue Engineering
5.3 Future Trends
  • 5.3.1 Advances in Treatment
5.4 Impact of Drivers and Restraints

6. North America Hypertrophic and Keloid Scar Treatment Market Regional Analysis

6.1 North America Hypertrophic and Keloid Scar Treatment Market Overview
6.2 North America Hypertrophic and Keloid Scar Treatment Market Revenue 2018-2027 (US$ Million)
6.3 North America Hypertrophic and Keloid Scar Treatment Market Forecast Analysis

7. North America Hypertrophic and Keloid Scar Treatment Market Analysis – by Scar Type

7.1 Hypertrophic
  • 7.1.1 Overview
  • 7.1.2 Hypertrophic: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Keloid
  • 7.2.1 Overview
  • 7.2.2 Keloid: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Hypertrophic and Keloid Scar Treatment Market Analysis – by Product Type

8.1 Laser Products
  • 8.1.1 Overview
  • 8.1.2 Laser Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Topical Products
  • 8.2.1 Overview
  • 8.2.2 Topical Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Injectables
  • 8.3.1 Overview
  • 8.3.2 Injectables: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Other Products
  • 8.4.1 Overview
  • 8.4.2 Other Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Hypertrophic and Keloid Scar Treatment Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Other Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Other Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Homecare
  • 9.3.1 Overview
  • 9.3.2 Other Products: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Hypertrophic and Keloid Scar Treatment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Key Country, 2021 and 2027 (%)
  • 10.1.1.1 North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Scar Type
    • 10.1.1.1.2 US: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Product Type
    • 10.1.1.1.3 US: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by End User
  • 10.1.1.2 Canada: North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Scar Type
    • 10.1.1.2.2 Canada: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Product Type
    • 10.1.1.2.3 Canada: North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Scar Type
    • 10.1.1.3.2 Mexico : North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by Product Type
    • 10.1.1.3.3 Mexico : North America Hypertrophic and Keloid Scar Treatment Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Hypertrophic and Keloid Scar Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Alliance Pharma PLC
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 HRA Pharma
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Mölnlycke Health Care AB.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Newmedical Technology Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Perrigo Company plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Rejûvaskin
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Smith & Nephew
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Sonoma Pharmaceuticals, Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Suneva Medical
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Hypertrophic and Keloid Scar Treatment Market

  1. Alliance Pharma PLC
  2. HRA Pharma
  3. Mölnlycke Health Care AB.
  4. Newmedical Technology Inc.
  5. Perrigo Company plc
  6. Rejûvaskin
  7. Smith & Nephew
  8. Sonoma Pharmaceuticals, Inc
  9. Suneva Medical
north-america-hypertrophic-and-keloid-scar-treatment-market